Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNET
1026
DELISTED
RigNet, Inc.
RNET
| $208K | 0.01% |
3,860
-1,916
| -33% | -$96K |
|
|
POLY
1027
DELISTED
Plantronics, Inc.
POLY
| $207K | 0.01% |
+4,300
| New | +$191K |
|
|
ALXN
1028
DELISTED
Alexion Pharmaceuticals
ALXN
| $207K | 0.01% |
1,326
-4,399
| -77% | -$695K |
|
1029
CSX Corp
CSX
$95.6B
| $206K | 0.01% |
+20,100
| New | +$196K |
|
1030
Jazz Pharmaceuticals
JAZZ
$16.5B
| $206K | 0.01% |
1,400
-2,700
| -66% | -$374K |
|
|
MITT
1031
TPG Mortgage Investment Trust
MITT
$213M
| $206K | 0.01% |
3,626
-275
| -7% | -$15.2K |
|
1032
Stagwell
STGW
$2.13B
| $206K | 0.01% |
9,564
-5,359
| -36% | -$120K |
|
1033
Toro Company
TTC
$9.47B
| $206K | 0.01% |
6,476
-124
| -2% | -$3.95K |
|
1034
Vertex Pharmaceuticals
VRTX
$139B
| $206K | 0.01% |
+2,178
| New | +$153K |
|
1035
Entegris
ENTG
$22B
| $205K | 0.01% |
+14,900
| New | +$177K |
|
1036
EQT Corp
EQT
$33.6B
| $205K | 0.01% |
+3,518
| New | +$202K |
|
|
ATW
1037
DELISTED
Atwood Oceanics
ATW
| $205K | 0.01% |
3,900
-3,200
| -45% | -$158K |
|
|
HAWK
1038
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $205K | 0.01% |
+7,639
| New | +$190K |
|
1039
Oneok
OKE
$58.8B
| $204K | 0.01% |
+2,994
| New | +$189K |
|
1040
Avis
CAR
$5.18B
| $203K | 0.01% |
+3,400
| New | +$186K |
|
1041
HCI Group
HCI
$2.27B
| $203K | 0.01% |
5,011
-13,289
| -73% | -$514K |
|
1042
TriNet
TNET
$3.24B
| $203K | 0.01% |
+8,430
| New | +$197K |
|
|
ARII
1043
DELISTED
American Railcar Industries, Inc.
ARII
| $203K | 0.01% |
+3,000
| New | +$193K |
|
1044
Associated Banc-Corp
ASB
$5.82B
| $202K | 0.01% |
+11,200
| New | +$197K |
|
1045
Globalstar
GSAT
$10.7B
| $202K | 0.01% |
+3,174
| New | +$163K |
|
1046
MBIA
MBI
$250M
| $202K | 0.01% |
18,287
-9,274
| -34% | -$114K |
|
|
JONE
1047
DELISTED
Jones Energy, Inc.
JONE
| $202K | 0.01% |
+536
| New | +$166K |
|
|
FFG
1048
DELISTED
FBL Financial Group
FFG
| $201K | 0.01% |
4,373
-600
| -12% | -$26.7K |
|
|
ACHN
1049
DELISTED
Achillion Pharmaceuticals
ACHN
| $201K | 0.01% |
+26,592
| New | +$106K |
|
|
VER
1050
DELISTED
VEREIT, Inc.
VER
| $199K | 0.01% |
+3,180
| New | +$204K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.